Amedisys traded at $100.99 this Thursday August 14th, increasing $0.01 or 0.01 percent since the previous trading session. Looking back, over the last four weeks, Amedisys gained 3.57 percent. Over the last 12 months, its price rose by 2.58 percent. Looking ahead, we forecast Amedisys to be priced at 97.96 by the end of this quarter and at 89.41 in one year, according to Trading Economics global macro models projections and analysts expectations.
Amedisys, Inc. is a healthcare services company, which is a multi-state provider of home health, hospice, and personal care services. The Company operates through three segments: Home Health, Hospice and Personal Care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 320 Medicare-certified home health care centers, 180 Medicare-certified hospice care centers and approximately 14 personal-care care centers in 39 states within the United States and the District of Columbia.